These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9598777)

  • 1. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.
    Russell P; Eley SM; Fulop MJ; Bell DL; Titball RW
    J Antimicrob Chemother; 1998 Apr; 41(4):461-5. PubMed ID: 9598777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.
    Russell P; Eley SM; Ellis J; Green M; Bell DL; Kenny DJ; Titball RW
    J Antimicrob Chemother; 2000 Jun; 45(6):813-8. PubMed ID: 10837435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
    Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
    J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
    Piercy T; Steward J; Lever MS; Brooks TJ
    J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection.
    Rotem S; Bar-Haim E; Cohen H; Elia U; Ber R; Shafferman A; Cohen O
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5406-8. PubMed ID: 22850512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    Caspar Y; Hennebique A; Maurin M
    J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Doxycycline and Ciprofloxacin for Treatment of Pneumonic Tularemia in Cynomolgus Macaques.
    Williams MS
    Clin Infect Dis; 2024 Jan; 78(Suppl 1):S7-S14. PubMed ID: 38294111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
    J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ
    Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Caspar Y; Maurin M
    Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.
    Wong JP; Yang H; Blasetti KL; Schnell G; Conley J; Schofield LN
    J Control Release; 2003 Oct; 92(3):265-73. PubMed ID: 14568408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic approaches for treatment of tularaemia: a review.
    Boisset S; Caspar Y; Sutera V; Maurin M
    Front Cell Infect Microbiol; 2014; 4():40. PubMed ID: 24734221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Macromolecular Antibiotic Platform for Inhalable Therapy against Aerosolized Intracellular Alveolar Infections.
    Das D; Chen J; Srinivasan S; Kelly AM; Lee B; Son HN; Radella F; West TE; Ratner DM; Convertine AJ; Skerrett SJ; Stayton PS
    Mol Pharm; 2017 Jun; 14(6):1988-1997. PubMed ID: 28394614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin for treatment of tularemia in children.
    Johansson A; Berglund L; Gothefors L; Sjöstedt A; Tärnvik A
    Pediatr Infect Dis J; 2000 May; 19(5):449-53. PubMed ID: 10819342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
    Syrjälä H; Schildt R; Räisäinen S
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):68-70. PubMed ID: 1864276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tularemia with ciprofloxacin.
    Scheel O; Reiersen R; Hoel T
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):447-8. PubMed ID: 1425715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Francisella tularensis as the cause of protracted fever.
    Antonitsch L; Weidinger G; Stanek G; Markowicz M
    BMC Infect Dis; 2020 May; 20(1):327. PubMed ID: 32380974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.